AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. FTRE
  4. [SCHEDULE 13G/A] Fortrea Holdings Inc. SEC Filing

[SCHEDULE 13G/A] Fortrea Holdings Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source:

Stock FTRE logo
Fortrea Holdings

NASDAQ:FTRE

FTRE Rankings

#4438 Ranked by Market Cap
N/A Ranked by Dividends

FTRE Latest News

Aug 4, 2025
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Jul 16, 2025
Fortrea Announces Date for Second Quarter 2025 Financial Results and Conference Call
Jun 24, 2025
Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin
Jun 12, 2025
Fortrea Adopts Limited-Duration Stockholder Rights Plan
Jun 11, 2025
Fortrea Names Anshul Thakral Chief Executive Officer

FTRE Latest SEC Filings

Aug 4, 2025
[Form 4] Fortrea Holdings Inc. Insider Trading Activity
Aug 4, 2025
[Form 3] Fortrea Holdings Inc. Initial Statement of Beneficial Ownership
Jul 29, 2025
[SCHEDULE 13G/A] Fortrea Holdings Inc. SEC Filing
Jul 15, 2025
[SCHEDULE 13G/A] Fortrea Holdings Inc. SEC Filing

FTRE Stock Data

494.35M
90.13M
0.4%
98.7%
15.83%
Biotechnology
Services-medical Laboratories
United States
DURHAM